| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $4.7M | +3.7% |
| Cost of Revenue | $2.0M | -3.4% |
| Gross Profit | $2.7M | +9.5% |
| R&D Expense | $56K | -97.6% |
| SG&A Expense | $16.1M | +2.8% |
| Operating Income | -$13.5M | +13.4% |
| Pre-tax Income | -$10.3M | — |
| Income Tax | $0 | — |
| Net Income | -$10.3M | -75.9% |
| EPS (Basic) | -$0.22 | -37.5% |
| EPS (Diluted) | -$0.22 | -37.5% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $3.5M | -3.9% |
| Accounts Receivable | $2.8M | +443.3% |
| Inventory | $5.0M | -19.4% |
| Current Assets | $11.4M | +9.1% |
| Total Assets | $15.4M | +2.0% |
| Current Liabilities | $1.8M | -86.2% |
| Total Liabilities | $3.9M | -73.6% |
| Stockholders' Equity |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$10.3M | -26.6% |
| Capital Expenditures | $100K | +733.3% |
| Investing Cash Flow | -$387K | -105.3% |
| Financing Cash Flow | $10.5M | +2150.9% |
| Free Cash Flow | -$10.4M | -27.7% |
| $11.5M |
| +4496.0% |